At A Glance
Healthcare marketing now runs across mixed-identity conditions, where authenticated data, contextual signals, and aggregated measurement all show up in the same campaign. Pharma brands need infrastructure that keeps DTC and HCP identity separate and still connects fragmented signals across activation, privacy, and measurement. Experian acts as an independent, privacy-first identity, data, and workflow layer for pharma marketers, designed specifically for this operating environment.Originally published in Digiday
Key takeaways
- Pharma campaigns now span environments with very different identity conditions, from strong addressability to contextual only signals, which makes coordination a core infrastructure challenge.
- Privacy and compliance rules require DTC (patient) and HCP (healthcare professional) data to stay in separate, non-overlapping workflows at every stage.
- Experian’s identity and workflow layer governs DTC tokenized matching and HCP deterministic National Provider Identifier (NPI) resolution as two distinct processes, never one merged identity path.
- Partner-enabled measurement connects exposure data to outcomes like script lift and qualified HCP engagement through trusted partners including IQVIA Digital, PurpleLab, and OptimizeRx.
A pharmaceutical brand launching a campaign today might rely on authenticated data in one environment, contextual signals in another, and aggregated measurement somewhere else entirely. That’s the reality of healthcare marketing right now, and most brands are still building the operational model to match it.
In a mixed-identity ecosystem, performance comes from the ability to coordinate multiple signal types across activation, privacy, and measurement workflows. Accuracy and scale depend on knowing which approach fits which environment and having the infrastructure to execute across all of them.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
Healthcare campaigns run across different signal conditions
Healthcare campaigns now run across environments with very different identity conditions, from fully addressable channels to contextual only placements. Digital advertising has long assumed that better identity leads to better targeting, frequency management, orchestration, and measurement, but healthcare has always operated with more constraints than most categories. Those constraints are becoming impossible to ignore as budgets move into connected TV (CTV), point-of-care, publisher-direct, programmatic and retail media-adjacent environments.
That shift changes the operating model. Marketers now have to manage audience strategy, supply quality and performance across channels that don’t support the same level of addressability, interoperability, or measurement visibility. In some environments, identity is strong and can support targeting and measurement. In others, identity is limited or unavailable, and marketers have to rely on contextual or aggregated signals. Managing across both environments is now a core infrastructure challenge for healthcare marketers, and it’s one that requires a deliberate strategy rather than a channel-by-channel patch.
Privacy risk is a media infrastructure issue
Privacy risk in healthcare marketing now shapes how campaigns get built and run from the ground up, extending well beyond compliance into media infrastructure itself. Tighter privacy and compliance expectations mean audience construction, exposure management, and outcomes analysis all get more complex once tracking is restricted.
Data can’t move freely across partners or workflows, and DTC and HCP data environments need to stay isolated from one another. This is especially true in pharma, where the stakes of a compliance misstep extend well beyond a campaign. This creates a more demanding operating model. Healthcare marketers have to balance identity-based and privacy-forward approaches while maintaining reach, relevance, and accountability. That balance requires governance that’s built into the infrastructure, not layered on top of it after the fact.
Experian acts as an independent, privacy-first identity, data, and workflow layer for pharma marketers, designed specifically for this operating environment:
These workflows are governed separately by design, with governed onboarding connecting fragmented DTC and HCP signals to activation-ready audiences without collapsing the two identity paths.
The mixed-identity playbook starts with matching the approach to the environment
The right mixed-identity approach depends on what each environment can support and what the campaign is needs to achieve. A pharmaceutical team may want more addressability, a publisher may only offer contextual or cohort signals, and a measurement partner may need exposure data, while platforms limit how identifiers can be shared.
Healthcare marketers need an operating model built for multiple identity conditions, with clear rules for how signals can be connected, activated, and measured without increasing privacy or compliance risk. That may include:
Experian’s infrastructure supports all three modes:
The missing layer in pharma marketing. Watch our Q&A
Supply quality is a prerequisite for measurement
Supply quality determines whether measurement in a mixed-identity environment can be trusted. When tracking and addressability vary across channels, advertisers need confidence that impressions ran in the right environments and under the right conditions before they can trust any downstream outcomes.
This is especially true in CTV and programmatic, where campaigns span fragmented supply paths, publishers, devices, and partners. Outcomes like script lift or provider engagement are only meaningful if the underlying exposure is reliable and well understood. In healthcare, this also ties directly to brand suitability and disclosure control. Curated supply, publisher-direct deals and placement-level transparency help campaigns run in appropriate environments and give measurement a more defensible foundation.
Clean rooms and tokenization support this, but their effectiveness depends on governance, interoperability, and whether insights can move cleanly across partners and workflows. Partner-enabled measurement, connecting exposure data to outcomes through trusted partners including IQVIA Digital, PurpleLab, and OptimizeRx, is structured in two steps:
- Link activation and measurement IDs without collapsing them into an open identity environment
- Produce aggregated, defensible outcomes including script lift, qualified HCP engagement, and verified delivery
Mixed-identity is the operating reality, and infrastructure is how you manage it
Mixed-identity is now the operating reality for healthcare marketing, not a temporary phase to work around. Performance depends on working across environments where identity is sometimes strong and sometimes limited by design. Healthcare marketers don’t need to pick a single identity approach and apply it everywhere. Building infrastructure that connects deterministic identity, tokenized matching, and contextual signals, keeping compliance, operational flexibility, and trust intact at every step, is what separates the brands managing this well from the ones still patching it channel by channel.
Talk to our team about your healthcare identity strategy
Whether you’re running DTC, HCP, or both, our team can help you build an infrastructure that works across identity environments. Let’s connect.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Mixed-identity means a healthcare campaign relies on more than one type of signal at once, such as authenticated data in one channel, contextual data in another, and aggregated measurement in a third. Pharma brands increasingly need infrastructure that coordinates all of these signal types together instead of treating each channel as a separate problem.
Experian keeps DTC and HCP identity in distinct, non-overlapping workflows so patient data and healthcare professional data never combine. DTC activation runs on high-fidelity tokenized matching, and HCP activation relies on deterministic National Provider Identifier (NPI) resolution using verified attributes like specialty and practice location.
Supply quality matters because outcomes like script lift or provider engagement only mean something if the underlying ad exposure is reliable. Curated supply, publisher-direct deals, and placement-level transparency give healthcare marketers a more defensible foundation before they trust any downstream measurement result.
Partner-enabled measurement connects exposure data to outcomes through trusted third parties such as IQVIA Digital, PurpleLab, and OptimizeRx, without merging activation and measurement identifiers into one open identity environment. The result is aggregated, defensible outcomes like script lift, qualified HCP engagement, and verified delivery.
Healthcare marketers don’t have to choose one approach over the other, since most campaigns already run across both conditions at the same time. Building infrastructure that connects deterministic identity, tokenized matching, and contextual signals is what allows a campaign to stay compliant while still reaching the right audience.
Latest posts
The Tapad Device Graph™ Complements Freckle’s IoT Capabilities to Extend Scale and Precision of Audience Data New York, NY — December 6, 2017 — Tapad, part of Experian, is the leader in cross-device marketing technology and Freckle IoT, the global leader in multi-touch, offline attribution, today announced they are partnering to provide brands with a holistic and insightful view of their customers, in predefined locations in all global markets. Starting today Freckle IoT will be leveraging the Tapad Device Graph™ to supplement the company’s data set to offer brands more granular attribution data. Consumer’s online behavior is becoming more and more complex, with the average consumer owning three or more devices and 35 percent of consumers converting on a different device from the one on which they started their research. These interactions become even more complicated when considering how online interactions and media impact offline sales. The collaboration between Tapad and Freckle, which combines Freckle IoT’s persistent location data with Tapad’s proprietary cross-device technology, is an important step in empowering brands with the information they need to better understand how digital media, consumed across multiple devices, is impacting offline attribution. Using its opt-in, first-party data, Freckle IoT helps brands measure the effectiveness of their advertising by independently matching media spend to in-store visits. Tapad’s technology extends Freckle’s data-set by allowing brands to access additional deterministic and probabilistic data, at scale and across all devices, to analyze consumer behavior ahead of in-store purchase. “Combining our technology with Tapad’s identity-driven solutions was a natural fit for our business,” said Neil Sweeney, founder and CEO at Freckle IoT. “With our unbiased, agnostic measurement and Tapad’s precise and privacy-safe data set, we knew this partnership would be a strong complement to providing more effective results for the needs of our brand partners.” For more information on Freckle IoT’s measurement offerings, please visit www.freckleiot.com. Contact us today
London – 24 November, 2017 – Tapad, part of Experian, is the leader in cross-device marketing technology and continues to broaden its reach across EMEA. The business today reported a 20 percent growth in the scope of its regional device graph, a data set used by organisations to map consumers to their devices, enabling better, more personalised cross-device marketing. This news complements Tapad’s recent expansion of its UK team with the hire of experienced solutions engineer, Davide Rosamilia. As the demand for cross-device technology solutions continues to grow around the globe, coupled with the emergence of regulations such as Europe’s General Data Protection Regulation (GDPR), Tapad is committed to offering suppliers the greatest level of insight without compromising consumer privacy. Since Tapad started licensing its proprietary Tapad Device GraphTM just over a year ago, demand for the company’s technology has experienced significant growth. New supply partnerships and proactive data sourcing have also meant an increase in devices across key markets, which contribute to the overall 20 percent growth of the EMEA device graph, including a 44 percent increase in the U.K., 47 percent in France, and 85 percent in Germany. “We’re continuing to invest heavily in growing our regional device graph, allowing us to better meet the needs of EMEA marketers as they strive to reach individuals with greater precision in some of the most tightly regulated marketplaces worldwide,” said Tom Rolph, VP EMEA, Tapad. “This year, we have also welcomed 10 new data suppliers whom we’ve helped to increase cross-device amplification, attribution and audience extension, helping to further set us apart in the marketplace and successfully expand our EMEA presence.” Available around the world, the Device Graph provides access to Tapad’s globally compliant and privacy-safe datasets across EMEA, APAC and the U.S., and offers deeper knowledge of consumer preferences, purchase intent, and conversion behaviors. “Tapad has shown a unique ability to adapt to the nuances of the local EMEA market and display impressive growth without sacrificing dedication to privacy,” said Alistair Hill, CEO and Co-founder at On Device Research. “When we started vetting technology vendors, we needed to be sure that we selected a partner that could offer compliant and privacy-safe datasets to operate within our stringent data standards. Tapad’s probabilistic solution offered us greater scale, greater device reach, and increased engagement without compromising on privacy.” Contact us today
The Tapad Device Graph™ Will Expand Sizmek’s Cross-Device Reach and Improve the Efficiency and Precision of Digital Advertising NEW YORK, November 16, 2017 — Tapad, part of Experian and a leader in cross-device marketing technology, today announced a new global partnership with Sizmek, the largest independent buy-side advertising platform delivering impressions that inspire. By integrating the Tapad Device Graph™, Sizmek will enhance its AI-powered predictive capabilities to deliver accurate, cross-device messaging at global scale in a privacy-safe environment. Combined with Sizmek’s existing data enablement, creative optimization and media execution capabilities, the proprietary Tapad Device Graph improves the efficiency and precision of digital advertising by accurately matching people and devices. This enables advertisers to get a clear view of individual customer journeys, achieve scale without compromising on efficiency, and uncover new opportunities for conversion. Sizmek’s customers will have access to Tapad’s globally compliant and privacy-safe datasets across the Americas, EMEA, and APAC. With deeper knowledge of consumer preferences, purchase intent and conversion behaviors, Sizmek and its customers are able to enhance advertising strategies including cross-device audience identification and more. “Tapad is known for their strong cross-device capabilities, and their offering is an excellent addition to our growing program for best-of-breed data and measurement partners” says Mike Caprio, Sizmek’s Chief Growth Officer. “For our customers, this partnership will add further people-based marketing precision and reach to our comprehensive offerings around creative optimization, data enablement and media execution.” This partnership comes at a time of a massive shift in the marketing technology industry. Companies like Tapad and Telenor, as well as Rocket Fuel and Sizmek, are joining forces to adopt those technologies that are most efficient and accurate at reaching consumers at scale in a personalized and non-intrusive way. The combination of Tapad and Sizmek’s offerings will provide international marketers with exceptional resources to lead a more cost effective and results driven campaign. Contact us today